STAT3 and neoplasm: While our data thus far argue strongly in favor of bazedoxifene conferring anti‐tumor activity directly on epithelial cells via a STAT3‐dependent, but SERM‐independent mechanism, our next aim was to assess whether the anti‐tumor activity of bazedoxifene was conferred in part by systemic, immune cell‐dependent mechanisms.